BactiQuant A/S (CPH:BACTIQ)
Denmark · Delayed Price · Currency is DKK 2.180
-0.040 (-1.80%)
Sep 11, 2026, 2:10 PM CET
BactiQuant Income Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 9.53 | 8.32 | 7.18 | 12.3 | 12.39 | 8.36 | |
Revenue Growth | 15.38% | 15.94% | -41.68% | -0.69% | 48.20% | 52.48% |
Cost of Revenue | 10.2 | 10.51 | 10.53 | 13.06 | 14.32 | 11.31 |
Gross Profit | -0.67 | -2.19 | -3.36 | -0.76 | -1.93 | -2.95 |
Selling, General & Admin | 8.29 | 8.73 | 7.65 | 8.74 | 10.41 | 8.85 |
Operating Expenses | 9.89 | 10.33 | 9.23 | 11.07 | 11.75 | 9.72 |
Operating Income | -10.56 | -12.52 | -12.58 | -11.83 | -13.68 | -12.68 |
Interest Expense | -1.27 | -1.43 | -1.44 | -1.52 | -0.55 | -0.83 |
Interest & Investment Income | 0.16 | 0.12 | 0.3 | 0.24 | 0.19 | 0.07 |
Other Non Operating Income (Expenses) | - | - | - | - | -0.15 | - |
EBT Excluding Unusual Items | -11.67 | -13.83 | -13.72 | -13.1 | -14.18 | -13.43 |
Pretax Income | -11.67 | -13.83 | -13.72 | -13.1 | -14.18 | -13.43 |
Income Tax Expense | - | - | - | - | - | 0.12 |
Net Income | -11.67 | -13.83 | -13.72 | -13.1 | -14.18 | -13.55 |
Net Income to Common | -11.67 | -13.83 | -13.72 | -13.1 | -14.18 | -13.55 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 34 | 30 | 23 | 21 | 19 | 18 |
Shares Outstanding (Diluted) | 34 | 30 | 23 | 21 | 19 | 18 |
Shares Change | 28.05% | 26.71% | 14.04% | 10.52% | 3.57% | 57.63% |
EPS (Basic) | -0.34 | -0.46 | -0.58 | -0.64 | -0.76 | -0.75 |
EPS (Diluted) | -0.34 | -0.46 | -0.58 | -0.64 | -0.76 | -0.75 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -11.49 | -10.51 | -12.97 | -8.16 | -17.11 | -14.66 |
Free Cash Flow Per Share | -0.34 | -0.35 | -0.55 | -0.40 | -0.92 | -0.81 |
Gross Margin | -7.02% | -26.36% | -46.79% | -6.14% | -15.55% | -35.34% |
Operating Margin | -110.80% | -150.53% | -175.39% | -96.13% | -110.40% | -151.68% |
Profit Margin | -122.42% | -166.29% | -191.25% | -106.51% | -114.50% | -162.12% |
Free Cash Flow Margin | -120.54% | -126.32% | -180.70% | -66.32% | -138.12% | -175.40% |
EBITDA | -10.04 | -12.01 | -12.01 | -11.37 | -11.95 | -11.81 |
EBITDA Margin | -105.36% | -144.33% | -167.35% | -92.39% | -96.47% | -141.24% |
D&A For EBITDA | 0.52 | 0.51 | 0.58 | 0.46 | 1.73 | 0.87 |
EBIT | -10.56 | -12.52 | -12.58 | -11.83 | -13.68 | -12.68 |
EBIT Margin | -110.80% | -150.53% | -175.39% | -96.13% | -110.40% | -151.68% |